Bernard D. Gary

Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/β-Catenin Signaling

Nan Li, Yaguang Xi, Heather N. Tinsley et al. · Molecular Cancer Therapeutics · 2013 · 134 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of PDE5 by Sulindac Sulfide Selectively Induces Apoptosis and Attenuates Oncogenic Wnt/β-Catenin–Mediated Transcription in Human Breast Tumor Cells

Heather N. Tinsley, Bernard D. Gary, Adam B. Keeton et al. · Cancer Prevention Research · 2011 · 112 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G

Heather N. Tinsley, Bernard D. Gary, Adam B. Keeton et al. · Molecular Cancer Therapeutics · 2009 · 100 citations · Full text

Medicine, Oncology, Pharmacology +14

A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity

Gary A. Piazza, Adam B. Keeton, Heather N. Tinsley et al. · Cancer Prevention Research · 2009 · 97 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors

Tamer M. Ibrahim, Khaled A. M. Abouzid, Jochen Lehmann et al. · Bioorganic & Medicinal Chemistry · 2009 · 94 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14